International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device (ADMIRE-ICD)

What is the purpose of this trial?

This is an event-driven Phase IIIb, multicentre, randomized, clinical study to demonstrate the efficacy of AdreView™ imaging for appropriately guiding the decision of implantable cardioverter defibrillator (ICD) implantation, in New York Health Association (NYHA) class II and III heart failure patients with 30%≤left ventricular ejection fraction (LVEF)≤35%%, and in particular, for identifying patients who are at low risk for sudden cardiac death and who would not benefit, or may suffer harm, from implantation of an ICD device.


Participation Guidelines

Ages: 18 years and older

Gender: Both


GE Healthcare

Dates: 04/03/2017 - 08/31/2019

Last Updated: 04/07/2017

Study HIC#: 2000020060

Get Involved

For more information about this study, contact:
Douglas W Heller
+1 203-737-3570
douglas.heller@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Michael Chen

Principal Investigator

Sub-Investigators